Story available to Subscribers Only

Thank you for your interest in CTFN content. To read this story, please request a free trial Request Free Trial CTFN is your source for in-depth news coverage on mergers, events, and major corporate actions, reported with the detail and accuracy commensurate with a professional investor’s perspective.
To learn more about our team’s reporting, please view the Insights section, or contact featured

360b /

UK Gaming Sources Expect Dramatically Reduced Maximum Stake for FOBTs

In an effort to reduce problem gambling in the United Kingdom, the government is likely to decrease the maximum stake on fixed odds betting terminals (FOBTs)featured

Competition Commission of India Has Asked Bayer for Remedies

The Competition Commission of India has asked Bayer for remedies in connection with the company’s planned takeover of Monsanto, sources told CTFN.featured

Melrose Instructed to Meet Unions and Give Guarantees over GKN Pensions

On the morning of March 6, the Business, Energy and Industrial Strategy Committee of the U.K. parliament met to hear evidence from witnesses concerning the fatefeatured

Melrose Sources Question GKN Deal with Dana

On March 2, GKN announced that further to its intention to separate its aerospace and automotive business in response to the unsolicited offer from Melrose, it had received “a number of approachesfeatured

Melrose Considers Its Plan Better for GKN

Melrose continues to speak to GKN and Melrose shareholders and feels confident that their plan for GKN is better than GKN’S standalone plan, sources close tofeatured

Bayer Timeline for EC Approval on Track, Only Big Ag Players in Nunhems Auction

The Monsanto-Bayer transaction is expected to be approved by the European Commissionfeatured

Third Party Comments to the EC on the Bayer Monsanto Deal are Expected Next Week, Sources Say

The European Commission’s case team in DG Competition sent out the non-confidential version of the RM (remedies) documentfeatured

GKN Shareholders Await Offer Document but Could Be Disappointed

GKN shareholders are waiting for the company’s defense document before making their next decisions, sources told CTFN. One large shareholder believes that shareholdersfeatured

Monsanto-Bayer EC Time Extension Good Sign for Deal

The delay in Bayer’s response to the European Commission’s Statement of Objections in the review of the Monsanto-Bayer merger by five days is seen asfeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.